Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 (1): Difference between revisions
From GxPlex
gxplex>GxPlexBot Import from GxPlex Excel |
Gxplex admin (talk | contribs) m 1 revision imported |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{ReferenceData | ||
| | |has_document=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 | ||
| | |module=1 | ||
| | |unit=1.5.4 | ||
| | |scope=HM | ||
| | |doc_part=Article 2 (1) | ||
| | |language=EN | ||
| | |entry_by=Florian Adragna | ||
|contributors= | |||
|tags=TAG-00019-Pri-Prü ++ TAG-00244-Def-ini ++ TAG-00135-Inv-ntr ++ TAG-00142-Mul-ent | |||
|tags_display=[[Glossary:TAG-00019-Pri-Prü|Principal investigator]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00135-Inv-ntr|Trial site]], [[Glossary:TAG-00142-Mul-ent|Multicentre trial]] | |||
|comment=Definition of chief investigator | |||
|content=[...] | |||
|- | |||
|- | |||
| | |||
| | |||
| | |||
= | |||
[...] | |||
“chief investigator” means— | “chief investigator” means— | ||
(a)in relation to a clinical trial conducted at a single trial site, the investigator for that site, or | (a)in relation to a clinical trial conducted at a single trial site, the investigator for that site, or | ||
(b)in relation to a clinical trial conducted at more than one trial site, the authorised health professional, whether or not he is an investigator at any particular site, who takes primary responsibility for the conduct of the trial; | (b)in relation to a clinical trial conducted at more than one trial site, the authorised health professional, whether or not he is an investigator at any particular site, who takes primary responsibility for the conduct of the trial; | ||
[...] | [...] | ||
}} | |||
Latest revision as of 13:49, 16 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 1 — Unit 1.5.4 |
| Scope | HM |
| Document part | Article 2 (1) |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Principal investigator, Definition, Trial site, Multicentre trial |
Content
[...] “chief investigator” means— (a)in relation to a clinical trial conducted at a single trial site, the investigator for that site, or (b)in relation to a clinical trial conducted at more than one trial site, the authorised health professional, whether or not he is an investigator at any particular site, who takes primary responsibility for the conduct of the trial; [...]
